TENANTS

Archive | Resident Company News

Kevin Conroy

As Exact Sciences’ Sales Surge, CEO Reflects on 10-Year Turnaround

A decade ago, Kevin Conroy took the CEO job at Exact Sciences, a cancer diagnostic firm on the brink of death. Five years later, the FDA greenlit the company’s first product, Cologuard, which marked the first non-invasive, stool-based DNA screening test approved for detecting colorectal cancer. In the five years since then, Exact (NASDAQ: EXAS) says it has screened […]

Continue Reading
Kathleen-Sebelius

Exact Sciences appoints former Kansas governor, HHS secretary Sebelius to its board of directors

Exact Sciences Corp., the maker of the Cologuard take home colon cancer test and one of the largest public companies in Wisconsin, has appointed Kathleen Sebelius, the former governor of Kansas and Secretary of the U.S. Department of Health and Human Services, to its board of directors, the Madison company announced Tuesday. “Secretary Sebelius understands […]

Continue Reading
illumina

Could we soon be able to detect cancer in 10 minutes?

About seven years ago, researchers at the US DNA sequencing company Illumina started to notice something odd. A new blood test it ran on 125,000 expectant mothers looking for genetic abnormalities such as Down’s syndrome in their foetuses returned some extremely unexpected signals in 10 cases. Chillingly, it dawned on them that the abnormal DNA they were […]

Continue Reading
JangoBio

Researchers with JangoBio, a Madison-based startup developing stem cell therapies, are set to begin testing on companion animals such as dogs within the next two months.

Bill Kohl, chief operating officer for JangoBio, says this marks a step forward in the company’s journey to bring its anti-aging therapy to market, starting with non-agricultural animals. “Things look promising,” Kohl told WisBusiness.com. “We’re working on refining the application, increasing and improving efficacy, and of course monitoring for safety.” JangoBio’s patent-pending therapy relies on […]

Continue Reading
Flugen

Study shows promising results for flu vaccine, Madison’s FluGen says

An experimental flu vaccine developed by a Madison company reduced flu virus levels and symptoms in people exposed to a mismatched strain, according to study results released Tuesday. The study by FluGen Inc., founded by UW-Madison scientists Yoshi Kawaoka and Gabriele Neumann, simulated the mismatch that frequently occurs when flu strains circulating in winter don’t […]

Continue Reading
invenra

Invenra and WARF Initiate a Collaboration to Discover and Develop Novel Therapeutics to Fight Neuroblastoma in Children

Invenra and WARF (Wisconsin Alumni Research Foundation) today announced they have entered into a collaboration to discover and develop a bispecific antibody therapeutic for the treatment of neuroblastoma, a cancer that is the third most common childhood cancer, after leukemia and brain tumors. The collaboration will use Invenra’s proprietary SNIPERTM technology to allow for precise […]

Continue Reading
excat-sciences

Exact Sciences to report $454-455M in total revenue, 71-percent growth for 2018

– Cologuard test volume increased 64 percent, with approximately 934,000 tests completed in 2018 – Nearly 15,000 health care providers ordered their first Cologuard test during the fourth quarter – We expect approximately 94 percent of patients who completed a Cologuard test during the fourth quarter to have no out-of-pocket costs READ FULL STORY  

Continue Reading